Researchers aimed to find a marker to accurately predict the prognosis of HNSCC and to find novel immune targets. The combo's use for conjunctival melanoma demonstrates the combinations high efficacy in treating complex disease. The single-center, prospective study evaluated patient questionnaires to assess quality of life and physical function. BANF1 is a prognostic biomarker that can promote tumor expression in patients with HNSCC. Oral bacteria are a risk factor for head and neck squamous cell cancer. A novel predictive digital pathology biomarker demonstrates high predictive response in HNC. A multi-university research collaboration spearheaded by Rice University has been award $18 million for breast, HNC research. Daily cannabis use over a period of years may be linked to a significantly increased risk of head and neck cancers. An AI-based tool demonstrated superior performance in the diagnosis of head and neck squamous cell carcinoma. Primary care providers are highly involved in opioid prescribing for HNC survivors. Edmonton Symptom Assessment System completion rates need to be improved in patients with HNC. Patients with head and neck cancer have increased rates of suicide compared with patients with other cancers. A gene model has the potential to serve as a prognostic indicator for patients with head and neck squamous cell carcinoma. The use of a 3D variable flip angle mapping technique is effective in patients with head and neck cancer undergoing CRT. Laryngeal squamous cell carcinoma (LSCC) is the most common squamous cell carcinoma; However, according to Lvsheng Qian ... A new study which analyzed price transparency and price variation for the treatment of thyroid cancer show that not ... A new study shows that people living in regions with high levels of artificial light at night face a higher risk of ... Patients undergoing head and neck cancer surgery do not have an increased risk of SARS-CoV-2 (COVID-19) infection, ... For patients with head and neck cancer (HNC), the prognosis may not be the greatest. Five-year survival ranges from 30% ... Oral cancer is more likely to spread in patients who experience high levels of pain, according to a study published in ...